Trueditors
Trueditors has been studied in 1 paper since 2026: none in people yet, 1 in cells; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, Feb 20, 2026: “Rational design of synthetic proteins using a genome-scale CRISPR screen”.
1 paper studies it3 findingsUpdated
See all 1 papers on trueditors
At a glance
The findings reach cells, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Cells1
What did studies of trueditors find?
2Studies of trueditors measured 2 outcomes: gene editing and cell killing (cytotoxicity).
Gene editing
upin human cells1
1 study
Gene editing
upin human cells1
Trueditors improve gene editing in human cells (>3-fold).
“improves precise editing in human pluripotent stem cells more than three-fold”
Cellshuman pluripotent stem cells
Rational design of synthetic proteins using a genome-scale CRISPR screen
bioRxiv : the preprint server for biologyPreprint
Trueditors increase gene editing in human cells.
“delivery of TruEditors via mRNA more than doubles the rate of chimeric antigen receptor (CAR) insertion into the TRAC locus of primary human T cells”
CellsmRNAprimary human T cells
Rational design of synthetic proteins using a genome-scale CRISPR screen
bioRxiv : the preprint server for biologyPreprint
Cell killing (cytotoxicity)
upin human cells1
1 study
Cell killing (cytotoxicity)
upin human cells1
Trueditors increase cell killing (cytotoxicity) in human cells.
“enhancing CAR T cell-directed tumor cell killing”
CellsmRNAprimary human T cells
Rational design of synthetic proteins using a genome-scale CRISPR screen
bioRxiv : the preprint server for biologyPreprint